Ken Fisher Immuno Gen, Inc. Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.09 - $19.87 $3.55 Million - $5.01 Million	-252,122 Reduced 35.87%	450,795 $7.15 Million
Q2 2023 Dec 12, 2023	BUY	$3.75 - $20.05 $945,457 - $5.06 Million	252,122 Added 55.93%	702,917 $13.3 Million
Q2 2023 Aug 08, 2023	SELL	$3.75 - $20.05 $573,000 - $3.06 Million	-152,800 Reduced 17.86%	702,917 $13.3 Million
Q1 2023 Dec 12, 2023	BUY	$3.67 - $4.92 $1.48 Million - $1.99 Million	403,942 Added 89.61%	854,737 $3.28 Million
Q1 2023 May 01, 2023	BUY	$3.67 - $4.92 $13,523 - $18,130	3,685 Added 0.43%	855,717 $3.29 Million
Q4 2022 Feb 03, 2023	BUY	$4.55 - $6.31 $1.22 Million - $1.69 Million	267,257 Added 45.7%	852,032 $4.23 Million
Q3 2022 Nov 08, 2022	BUY	$4.48 - $6.47 $911,989 - $1.32 Million	203,569 Added 53.4%	584,775 $2.8 Million
Q2 2022 Aug 09, 2022	BUY	$3.15 - $5.76 $2,274 - $4,158	722 Added 0.19%	381,206 $1.72 Million
Q1 2022 May 05, 2022	BUY	$4.26 - $7.48 $615,582 - $1.08 Million	144,503 Added 61.24%	380,484 $1.81 Million
Q4 2021 Feb 02, 2022	BUY	$4.75 - $7.5 $718,119 - $1.13 Million	151,183 Added 178.29%	235,981 $1.75 Million
Q3 2021 Oct 26, 2021	SELL	$5.02 - $6.59 $1,360 - $1,785	-271 Reduced 0.32%	84,798 $481,000
Q2 2021 Jul 27, 2021	BUY	$5.79 - $8.6 $249,705 - $370,892	43,127 Added 102.83%	85,069 $561,000
Q1 2021 Apr 27, 2021	BUY	$6.5 - $10.53 $9,665 - $15,658	1,487 Added 3.68%	41,942 $340,000
Q4 2020 Jan 29, 2021	SELL	$3.7 - $7.66 $3,700 - $7,660	-1,000 Reduced 2.41%	40,455 $261,000
Q3 2020 Nov 10, 2020	BUY	$3.45 - $4.89 $3,422 - $4,850	992 Added 2.45%	41,455 $149,000
Q2 2020 Aug 07, 2020	SELL	$3.32 - $5.34 $3,396 - $5,462	-1,023 Reduced 2.47%	40,463 $186,000
Q1 2020 Apr 28, 2020	BUY	$2.12 - $6.8 $2,226 - $7,140	1,050 Added 2.6%	41,486 $141,000
Q4 2019 Feb 12, 2020	SELL	$2.25 - $5.8 $276,288 - $712,211	-122,795 Reduced 75.23%	40,436 $206,000
Q3 2019 Oct 29, 2019	SELL	$2.22 - $3.39 $526 - $803	-237 Reduced 0.14%	163,231 $395,000
Q2 2019 Jul 30, 2019	BUY	$1.8 - $3.3 $47,514 - $87,110	26,397 Added 19.26%	163,468 $355,000
Q1 2019 Apr 22, 2019	SELL	$2.41 - $5.91 $2,761 - $6,772	-1,146 Reduced 0.83%	137,071 $371,000
Q4 2018 Jan 25, 2019	BUY	$3.94 - $9.7 $4,995 - $12,299	1,268 Added 0.93%	138,217 $663,000
Q3 2018 Oct 24, 2018	BUY	$8.6 - $11.26 $1,212 - $1,587	141 Added 0.1%	136,949 $1.3 Million
Q2 2018 Jul 09, 2018	SELL	$9.52 - $12.15 $1,113 - $1,421	-117 Reduced 0.09%	136,808 $1.33 Million
Q1 2018 May 11, 2018	SELL	$6.7 - $12.95 $1.82 Million - $3.51 Million	-271,379 Reduced 66.46%	136,925 $1.44 Million
Q1 2018 Apr 19, 2018	BUY	$6.7 - $12.95 $1.67 Million - $3.24 Million	249,828 Added 157.64%	408,304 $4.3 Million
Q4 2017 Jan 24, 2018	SELL	$5.07 - $7.92 $456,807 - $713,592	-90,100 Reduced 36.25%	158,476 $1.02 Million
Q3 2017 Oct 17, 2017	BUY	$5.4 - $8.47 $1.34 Million - $2.11 Million	248,576	248,576 $1.9 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account